(Q42467051)

1 November 2017

The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors (English)

1 reference

1 November 2017

0 references

Andringa G

1

1 reference

1 November 2017

Drukarch B

2

1 reference

1 November 2017

Leysen JE

3

1 reference

1 November 2017

Cools AR

4

1 reference

1 November 2017

Stoof JC

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

European Journal of Pharmacology

1 November 2017

1 reference

1 November 2017

364

1 reference

1 November 2017

1

1 reference

1 November 2017

33-41

1 reference

Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Effects of an alpha2 antagonist ina 20-year-old Java monkey with MPTP-induced parkinsonian signs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

A68930: a potent agonist selective for the dopamine D1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Supersensitivity in rat caudate nucleus: Effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

A microcomputer program for fitting enzyme inhibition rate equations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Locomotor behaviour of selective dopamine agonists in mice: is endogenous dopamine the only catecholamine involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2 agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Two dopamine receptors: biochemistry, physiology and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Dopamine D1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900825-5

10.1016/S0014-2999(98)00825-5

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference